Tinzaparin for the treatment of foetal growth retardation

Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Tinzaparin for the treatment of foetal growth retardation : An open-labelled randomized clinical trial. / Hansen, Anette Tarp; Sandager, Puk; Ramsing, Mette; Petersen, Olav Bennike Bjørn; Salvig, Jannie D; Juul, Svend; Uldbjerg, Niels; Hvas, Anne-Mette.

In: Thrombosis Research, Vol. 170, 2018, p. 38-44.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Hansen, AT, Sandager, P, Ramsing, M, Petersen, OBB, Salvig, JD, Juul, S, Uldbjerg, N & Hvas, A-M 2018, 'Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial', Thrombosis Research, vol. 170, pp. 38-44. https://doi.org/10.1016/j.thromres.2018.08.006

APA

Hansen, A. T., Sandager, P., Ramsing, M., Petersen, O. B. B., Salvig, J. D., Juul, S., Uldbjerg, N., & Hvas, A-M. (2018). Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial. Thrombosis Research, 170, 38-44. https://doi.org/10.1016/j.thromres.2018.08.006

Vancouver

Hansen AT, Sandager P, Ramsing M, Petersen OBB, Salvig JD, Juul S et al. Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial. Thrombosis Research. 2018;170:38-44. https://doi.org/10.1016/j.thromres.2018.08.006

Author

Hansen, Anette Tarp ; Sandager, Puk ; Ramsing, Mette ; Petersen, Olav Bennike Bjørn ; Salvig, Jannie D ; Juul, Svend ; Uldbjerg, Niels ; Hvas, Anne-Mette. / Tinzaparin for the treatment of foetal growth retardation : An open-labelled randomized clinical trial. In: Thrombosis Research. 2018 ; Vol. 170. pp. 38-44.

Bibtex

@article{2a9c214a3cd945cabc02169c571a7e21,

title = "Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial",

abstract = "OBJECTIVE: Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase birth weight in ongoing FGR pregnancies.METHODS: An open-labelled randomized trial in Denmark during 2011-2016, including singleton pregnant women with FGR (estimated foetal weight ",

author = "Hansen, {Anette Tarp} and Puk Sandager and Mette Ramsing and Petersen, {Olav Bennike Bj{\o}rn} and Salvig, {Jannie D} and Svend Juul and Niels Uldbjerg and Anne-Mette Hvas",

year = "2018",

doi = "10.1016/j.thromres.2018.08.006",

language = "English",

volume = "170",

pages = "38--44",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Pergamon Press",

}

RIS

TY - JOUR

T1 - Tinzaparin for the treatment of foetal growth retardation

T2 - An open-labelled randomized clinical trial

AU - Hansen, Anette Tarp

AU - Sandager, Puk

AU - Ramsing, Mette

AU - Petersen, Olav Bennike Bjørn

AU - Salvig, Jannie D

AU - Juul, Svend

AU - Uldbjerg, Niels

AU - Hvas, Anne-Mette

PY - 2018

Y1 - 2018

N2 - OBJECTIVE: Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase birth weight in ongoing FGR pregnancies.METHODS: An open-labelled randomized trial in Denmark during 2011-2016, including singleton pregnant women with FGR (estimated foetal weight 

AB - OBJECTIVE: Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase birth weight in ongoing FGR pregnancies.METHODS: An open-labelled randomized trial in Denmark during 2011-2016, including singleton pregnant women with FGR (estimated foetal weight 

U2 - 10.1016/j.thromres.2018.08.006

DO - 10.1016/j.thromres.2018.08.006

M3 - Journal article

C2 - 30114561

VL - 170

SP - 38

EP - 44

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -

ID: 227526952

Forskning